Recent Insights
»
COVID-19 Insights from WCG
»
PART 11: The Impact of COVID-19 on Oncology Research: Immediate and Long-term Effects
Other content in this Stream

Jonca Bull, MD: We Should Not Be Surprised — COVID-19 Disparities Lay Bare What’s Been There All Along
In this episode, former Assistant FDA Commissioner Jonca Bull, MD, discusses racial disparities in healthcare, how COVID-19 has made them impossible to ignore, and how this highlights the need for div

Dr. Edith Mitchell, MD: COVID-19 Doesn't Play Fair — What We Need to Understand About Racial Disparities

Dr. David Fajgenbaum, MD, Castleman’s Disease Survivor, Facing COVID-19 with Research, Action, and Hope

COVID-19 Insights from Former FDA Commissioner, Scott Gottlieb, MD
The coronavirus has spread beyond the point of containment, and there’s a looming shortage of personal protective equipment. Hear insights from former FDA Commissioner, Scott Gottlieb, MD.

COVID-19 Preparedness for Health Care Institutions with Dr. Paul Biddinger of Massachusetts General Hospital
Save the Data. Protect the Patients. Prepare for What Comes Next: Remote Clinical Research Coordinators
Infectious Disease Challenge Studies: Ethical Issues in Causing Disease for Medical Knowledge

PART 12: Public Awareness of Clinical Research and the Path To Diversity in Clinical Trials

PART 10: Unique Challenges and Opportunities for Emerging Biopharma Companies with Focused Pipelines